Compare Icl Group Ltd (ICL) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Icl Group Ltd vs Twist Bioscience Corp — how do they compare? Icl Group Ltd trades at $5.01 (market cap $6.65B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Icl Group Ltd is the larger of the two by market cap, and Icl Group Ltd pays a 3.77% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| ICL | TWST | |
|---|---|---|
Market Cap | $6.65B | $5.45B |
Sector | Basic Materials | Health |
52-Week High | $7.03 | $102.88 |
52-Week Low | $4.80 | $24.16 |
Enterprise Value | $9.22B | $5.37B |
Dividend Yield | 3.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ICL trades at $5.25, up 3.96% today, with neutral technical signals and mixed earnings history. The company maintains stable cash flow and recently completed an $800 million senior notes offering. Valuation metrics show a P/E of 24.05 and P/S of 0.88, while profitability margins remain modest. All four covering analysts rate the stock as Hold.
Outlook is cautious due to flat analyst sentiment and declining profit margins, though operational cash flow supports dividend payments. Key risks include raw material costs and foreign exchange volatility. The stock offers income via dividends but lacks near-term growth catalysts.
TWST trades at $95.86, up 2.14% today, with a bullish technical signal and strong institutional interest. Revenue growth is robust, rising from $204M in 2022 to $377M in 2025, though the company remains unprofitable with a net income margin of -19.85%. Recent news highlights AI-driven collaborations and earnings beats, but cash flow trends show persistent operational losses.
The outlook is mixed; analyst consensus is bullish with a $91.63 price target, but profitability challenges and negative cash flows pose significant risks. Investment opportunity lies in continued revenue expansion and AI partnerships, while execution risks and high valuations require caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Icl Group Ltd
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.
Read more on ICL →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
